![]() |
|
|
Vol. 61, Issue 2, 320-325, February 2002
Departments of Chemistry & Biochemistry and Pharmacology, Cancer
Center, University of California, San Diego, La Jolla, California
(A.S., C.P.S., R.H.T.) and Department of Gastroenterology and
Hepatology, Medizinische Hochschule Hannover, Hannover, Germany
(M.P.M.)
NAD(P)H:quinone oxidoreductase (NQO1) and dihydronicotinamide
riboside:quinone oxidoreductases (NQO2) are cytosolic flavoproteins that catalyze the two-electron reduction of quinones and quinoid compounds to hydroquinones, thereby promoting detoxification and preventing the formation of highly reactive oxygen species, which lead
to DNA and cell damage. Two NQO isoforms, designated NQO1 and NQO2,
have been cloned and sequenced. To elucidate their role in
carcinogenesis, the gene expression of human NQO1 and NQO2 in paired
normal and tumor tissue samples was examined. Quantitative triplex
reverse transcriptase polymerase chain reaction was employed to
analyze NQO1 and NQO2 mRNA expression in normal hepatic and biliary
tissue as well as in cholangiocellular carcinomas (CCC), hepatocellular
carcinomas (HCC), and focal nodular hyperplasias (FNH). Coexpression of
-actin RNA was used as an internal reference standard and linear
ranges of transcript amplification were established for each sample. In
normal hepatocellular tissue, the two NQO isoforms were differentially
regulated, with a higher expression of NQO2 than NQO1. Malignant
hepatocellular tissue (HCC), however, displayed up-regulation of NQO1
and down-regulation of NQO2. Regulation of either transcript was not
seen in benign hepatocellular tumor tissue (FNH), which indicates a
reciprocal control of NQO genes in hepatocarcinogenesis. Normal biliary
tissue expressed a significantly higher level of NQO1 transcripts
compared with normal liver, whereas biliary NQO2 levels were
significantly lower than in hepatocellular tissue. Comparing the levels
of expression in normal and malignant biliary tissue (CCC), no
significant differences were noted between the expression levels of
either transcript. Thus, this study provides evidence for differential
hepatic and biliary regulation of both NQO1 and NQO2.
This article has been cited by other articles:
![]() |
K. S. Ahn, X. Gong, G. Sethi, M. M. Chaturvedi, A. K. Jaiswal, and B. B. Aggarwal Deficiency of NRH:Quinone Oxidoreductase 2 Differentially Regulates TNF Signaling in Keratinocytes: Up-regulation of Apoptosis Correlates with Down-regulation of Cell Survival Kinases Cancer Res., October 15, 2007; 67(20): 10004 - 10011. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Siegel, D. L. Gustafson, D. L. Dehn, J. Y. Han, P. Boonchoong, L. J. Berliner, and D. Ross NAD(P)H:Quinone Oxidoreductase 1: Role as a Superoxide Scavenger Mol. Pharmacol., May 1, 2004; 65(5): 1238 - 1247. [Abstract] [Full Text] |
||||